Join the Sarcoma Disease Site Work Group for an in-depth discussion on managing pulmonary metastases in soft tissue sarcoma. This session will explore strategies for addressing both synchronous and metachronous lung metastases. Participants will also learn about the different treatment modalities available for sarcoma lung metastases, including radiation, surgery, and chemotherapy.
The faculty for this activity are listed below:
Carolyn Nessim, MD (Planner/Moderator)
The Ottawa Hospital
Mara Antonoff, MD (Faculty)
MD Anderson Cancer Center
Graham Cook, MD, FACS (Faculty)
The Ottawa Hospital
Marium Husain, MD (Faculty)
Ohio State Medical
Requirements for Earning Credit and Method of Participation
Estimated Time to Complete Activity
As required by the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all planners, reviewers, presenters, instructors, moderators, authors, and other individuals in a position to control or influence the content of an activity must disclose ALL financial relationships with any ineligible company that have occurred within the past 24 months. Ineligible companies are those that cannot be accredited in the ACCME System and whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
As the accredited provider, SSO is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships of any dollar amount are defined as relevant if the educational content is related to the business lines or products of the ineligible company.
All identified conflicts of interest must be mitigated, and the educational content vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. If you perceive bias while participating in this activity, please advise us of the circumstances when completing your postactivity evaluation form.
All identified conflicts of interests have been mitigated.
Faculty
Carolyn Nessim, MD (Planner/Moderator) has disclosed no financial relationships.
Mara Antonoff, MD (Faculty) has disclosed the following financial relationships: Merck (Consultant), Astra Zeneca (Counsultant), Bristol Myers Squibb (Consultant), Ethicon (Consultant).
Graham Cook, MD, FACS (Faculty) has disclosed no financial relationships.
Marium Husain, MD (Faculty) has disclosed no financial relationships.
Planners, Reviewers, and Staff
Carlos Contreras, MD, CME Committee Reviewer, has disclosed no financial relationships.
Devin Winkler, Society of Surgical Oncology, has disclosed no financial relationships.
Cara Roth, Society of Surgical Oncology, has disclosed no financial relationships.
The primary purpose of the Society of Surgical Oncology's internet live course is educational. Information, as well as technologies, products, and/or services, discussed are intended to inform participants about the knowledge, techniques, and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty, and the Society of Surgical Oncology disclaims any and all liability for damages to any individual using the materials and for all claims which may result from the use of information, technologies, products, and/or services discussed.
This educational activity may include discussions of unlabeled/unapproved uses of drugs or devices. Participants are advised to refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Opinions expressed in this educational activity are those of the expert contributors and do not necessarily represent the views of the Society of Surgical Oncology or any other organization associated with this activity.